You just read:

FDA Clears Xavant Technology's Stimpod NMS460 Non-Invasive Neuromodulation Device for Treatment of Chronic Intractable Pain

News provided by

Xavant Technology (Pty) Ltd

Aug 01, 2017, 13:00 ET